<div id="readability-page-1"><div><p>As the U.S. stock market continues to climb, with indices like the Nasdaq and S&amp;P 500 reaching new highs, investors are exploring various opportunities in different segments of the market. Penny stocks, a term that may seem outdated yet remains significant, represent smaller or less-established companies that can offer potential value. By focusing on those with solid financials and growth potential, investors might uncover promising opportunities among these lesser-known stocks.</p><h3>Top 10 Penny Stocks In The United States</h3><table><tbody><tr><td><strong>Name</strong></td><td><strong>Share Price</strong></td><td><strong>Market Cap</strong></td><td><strong>Rewards &amp; Risks</strong></td></tr><tr><td>Dingdong (Cayman) (DDL)</td><td>$2.04</td><td>$437.18M</td><td>✅ 4 ⚠️ 0 View Analysis &gt;</td></tr><tr><td>Waterdrop (WDH)</td><td>$1.97</td><td>$705.24M</td><td>✅ 4 ⚠️ 0 View Analysis &gt;</td></tr><tr><td>WM Technology (MAPS)</td><td>$1.16</td><td>$201.8M</td><td>✅ 4 ⚠️ 2 View Analysis &gt;</td></tr><tr><td>Performance Shipping (PSHG)</td><td>$1.90</td><td>$23.5M</td><td>✅ 4 ⚠️ 2 View Analysis &gt;</td></tr><tr><td>CI&amp;T (CINT)</td><td>$4.98</td><td>$636.96M</td><td>✅ 5 ⚠️ 0 View Analysis &gt;</td></tr><tr><td>Golden Growers Cooperative (GGRO.U)</td><td>$5.00</td><td>$77.45M</td><td>✅ 2 ⚠️ 5 View Analysis &gt;</td></tr><tr><td>BAB (BABB)</td><td>$0.97</td><td>$7.21M</td><td>✅ 2 ⚠️ 3 View Analysis &gt;</td></tr><tr><td>Lifetime Brands (LCUT)</td><td>$3.81</td><td>$88.82M</td><td>✅ 3 ⚠️ 2 View Analysis &gt;</td></tr><tr><td>Universal Safety Products (UUU)</td><td>$4.99</td><td>$10.96M</td><td>✅ 2 ⚠️ 3 View Analysis &gt;</td></tr><tr><td>Resources Connection (RGP)</td><td>$4.92</td><td>$165.51M</td><td>✅ 3 ⚠️ 1 View Analysis &gt;</td></tr></tbody></table><p>Click here to see the full list of 362 stocks from our  US Penny Stocks screener.</p><p>Here we highlight a subset of our preferred stocks from the screener.</p><h2>Rapid Micro Biosystems (RPID)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p><p><strong>Overview:</strong> Rapid Micro Biosystems, Inc. is a life sciences technology company that offers products for detecting microbial contamination in the manufacturing of pharmaceuticals, medical devices, and personal care products across various international markets, with a market cap of $167.56 million.</p><p><strong>Operations:</strong> The company generates revenue primarily from Systems and Related LIMS Connection Software, Consumables, and Services, totaling $30.29 million.</p><p><strong>Market Cap:</strong> $167.56M</p><p>Rapid Micro Biosystems, Inc., with a market cap of US$167.56 million, is navigating the challenging landscape of penny stocks by focusing on revenue growth and financial stability. Despite being unprofitable with a negative return on equity, the company has shown consistent revenue increases, reporting US$14.47 million for the first half of 2025 compared to US$12.23 million in 2024. It remains debt-free and has recently secured a US$45 million loan facility to support its global expansion efforts and enhance manufacturing efficiencies. The management team is experienced, and short-term liabilities are well-covered by assets worth US$60.1 million.</p><ul><li>Click to explore a detailed breakdown of our findings in Rapid Micro Biosystems' financial health report.</li><li>Evaluate Rapid Micro Biosystems' prospects by accessing our earnings growth report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8cf9af1a-87ce-436e-aae4-9eeaabf35533/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8cf9af1a-87ce-436e-aae4-9eeaabf35533/chart/debt-equity-history-analysis"/><figcaption>RPID Debt to Equity History and Analysis as at Oct 2025</figcaption></figure><h2>Nuvation Bio (NUVB)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Nuvation Bio Inc. is a clinical-stage biopharmaceutical company that develops therapeutic candidates for oncology, with a market cap of approximately $1.27 billion.</p><p><strong>Operations:</strong> Nuvation Bio generates revenue from its oncology development activities, totaling $14.36 million.</p><p><strong>Market Cap:</strong> $1.27B</p><p>Nuvation Bio Inc., a clinical-stage biopharmaceutical company with a market cap of US$1.27 billion, is navigating the penny stock landscape by advancing its oncology pipeline, particularly with IBTROZI™ (taletrectinib). Recent approvals from Japan's MHLW and the U.S. FDA highlight its potential in treating ROS1-positive non-small cell lung cancer. Despite being unprofitable, Nuvation Bio reported US$7.92 million in revenue for the first half of 2025 and maintains strong liquidity with short-term assets exceeding liabilities significantly. The company has more cash than debt but faces challenges like high volatility and an inexperienced board of directors.</p><ul><li>Unlock comprehensive insights into our analysis of Nuvation Bio stock in this financial health report.</li><li>Assess Nuvation Bio's future earnings estimates with our detailed growth reports.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/1d2ddebb-038e-4cd4-82b7-a76373f619a3/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/1d2ddebb-038e-4cd4-82b7-a76373f619a3/chart/financial-position-analysis"/><figcaption>NUVB Financial Position Analysis as at Oct 2025</figcaption></figure><h2>Waterdrop (WDH)</h2><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Waterdrop Inc. operates as an online insurance brokerage in China, connecting users with insurance products, and has a market cap of approximately $705.24 million.</p><p><strong>Operations:</strong> The company's revenue is primarily derived from its insurance segment, which generated CN¥2.78 billion, complemented by CN¥153.68 million from crowd funding activities.</p><p><strong>Market Cap:</strong> $705.24M</p><p>Waterdrop Inc., with a market cap of approximately US$705.24 million, has shown robust financial performance in the penny stock arena. The company reported significant earnings growth, with net income rising to CN¥140.16 million for Q2 2025, up from CN¥88.29 million a year ago. Its short-term assets (CN¥4 billion) comfortably cover liabilities, and it maintains strong liquidity by having more cash than debt. Despite trading below its estimated fair value and boasting high-quality earnings, Waterdrop's return on equity remains low at 8.6%. Recent strategic moves include a share repurchase program worth US$50 million and dividend affirmations enhancing shareholder value.</p><ul><li>Take a closer look at Waterdrop's potential here in our financial health report.</li><li>Examine Waterdrop's earnings growth report to understand how analysts expect it to perform.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/5ec70547-526e-42d6-ac6d-8a4bcdf65c9f/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/5ec70547-526e-42d6-ac6d-8a4bcdf65c9f/chart/financial-position-analysis"/><figcaption>WDH Financial Position Analysis as at Oct 2025</figcaption></figure><h2>Taking Advantage</h2><ul><li>Get an in-depth perspective on all 362  US Penny Stocks by using our screener here.</li><li>Searching for a Fresh Perspective? The end of cancer? These 28 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p></div></div>

RPID

NUVB

<p>As the U.S. stock market rises, investors are eyeing penny stocks for potential value. Notable mentions include Rapid Micro Biosystems (RPID), a life sciences tech firm with a market cap of $167.56 million, focusing on microbial contamination detection. Despite being unprofitable, it reported revenue growth and secured a $45 million loan for expansion. Nuvation Bio (NUVB), a biopharmaceutical company with a $1.27 billion market cap, is advancing its oncology pipeline. Waterdrop (WDH), an online insurance brokerage in China, has shown strong earnings growth and maintains robust liquidity.</p>

Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch